Search - tctmd.com

Displaying 381 - 400 of 438

Sort: Relevancy | Date

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

FFR-Guided CABG Reduces Number of Grafts in Patients with Intermediate Stenosis

September 04, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2013

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

Yael L. Maxwell

September 03, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

News Conference News ESC 2013

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Conference News ESC 2013

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Yael L. Maxwell

September 02, 2013

News Conference News ESC 2013

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Caitlin E. Cox

September 02, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

News Conference News ESC 2013

TASTE: No Appetite for Manual Thrombus Aspiration

September 01, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

Advertisement

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

FFR-Guided CABG Reduces Number of Grafts in Patients with Intermediate Stenosis

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

TASTE: No Appetite for Manual Thrombus Aspiration

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content